Publications by authors named "Anne-Catherine Abel"

Cytotoxic payloads for drug conjugates suitable for directed tumor therapy need to be highly potent and require a functional group for conjugation with the homing device (antibody, peptide, or small molecule). Cryptophycins are cyclodepsipeptides that stand out from the realm of natural products due to their extraordinarily high cytotoxicity. However, the installation of a suitable conjugation handle without compromising the toxicity is highly challenging.

View Article and Find Full Text PDF

Cryptophycins are microtubule-targeting agents (MTAs) that belong to the most potent antimitotic compounds known to date; however, their exact molecular mechanism of action remains unclear. Here, we present the 2.2 Å resolution X-ray crystal structure of a potent cryptophycin derivative bound to the αβ-tubulin heterodimer.

View Article and Find Full Text PDF
Article Synopsis
  • * Most known tubulin binders come from natural products, with only one developed using rational drug design, but many show unwanted side effects in patients.
  • * There is a need for safer tubulin-targeting agents, and the text discusses using computer-aided design techniques to guide the development of new compounds based on existing structural data.
View Article and Find Full Text PDF

Invited for the cover of this issue are the groups of Professors Passarella and Pieraccini at the University of Milan, in collaboration with some of the members of TubInTrain consortium. The image depicts work with the elements of nature, in particular the destabilising effect of maytansinol (the constellation) on microtubules (the trees). Read the full text of the article at 10.

View Article and Find Full Text PDF

Maytansinoids are a successful class of natural and semisynthetic tubulin binders, known for their potent cytotoxic activity. Their wider application as cytotoxins and chemical probes to study tubulin dynamics has been held back by the complexity of natural product chemistry. Here we report the synthesis of long-chain derivatives and maytansinoid conjugates.

View Article and Find Full Text PDF
Article Synopsis
  • Lymphomas are common cancers with ongoing challenges in treatment, especially for patients whose tumors relapse after initial responses.
  • Research has identified a series of compounds called [1,2]oxazolo[5,4-e]isoindoles, which target the colchicine site of tubulin and show potential as effective treatments for refractory lymphomas.
  • Two specific compounds from this series demonstrated significant efficacy against various lymphoma types, achieving high inhibition of colchicine binding, indicating their promise as new therapeutic options.
View Article and Find Full Text PDF

Maytansinol is a valuable precursor for the preparation of maytansine derivatives (known as maytansinoids). Inspired by the intriguing structure of the macrocycle and the success in targeted cancer therapy of the derivatives, we explored the maytansinol acylation reaction. As a result, we were able to obtain a series of derivatives with novel modifications of the maytansine scaffold.

View Article and Find Full Text PDF

Since the revelation of noscapine's weak anti-mitotic activity, extensive research has been conducted over the past two decades, with the goal of discovering noscapine derivatives with improved potency. To date, noscapine has been explored at the 1, 7, 6', and 9'-positions, though the 1,3-benzodioxole motif in the noscapine scaffold that remains unexplored. The present investigation describes the design, synthesis and pharmacological evaluation of noscapine analogues consisting of modifications to the 1,3-benzodioxole moiety.

View Article and Find Full Text PDF